This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Medical science Remove Safety Remove Transportation Related Topics
Medical sales reps Ethics Medical sales Specialization Healthcare Doctors Physicians Training Patients Sales More Related Topics >
article thumbnail

Dapagliflozin approved for heart failure across LVEFs

European Pharmaceutical Review

DECEMBER 12, 2022

AstraZeneca’s dapagliflozin is an oral, once-daily selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2). AstraZeneca’s oral dapagliflozin drug. It is already approved in Great Britain for the treatment of insufficiently controlled type 2 diabetes (T2D), symptomatic chronic HFrEF and chronic kidney disease (CKD).

Transportation 103
Transportation Medical science Safety Patients 103
article thumbnail

From Europe To The U.S.: A Medtech Executive’s Career Chronicle With Fred Colen

Evolve Your Success

DECEMBER 19, 2023

In the end, I decided to become an engineer but from the get-go specialized in medical technology. They allowed me to do some classes in medical science, which was very nice. I got going from the get-go in medical technology. I was inspired by it. Before you continue that, we’ve got to let the audience know what you do.

Engineering 52
Engineering Patients Medical Sales 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024